Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.

2.

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven

3.

TikTok creators perform 'roles' when sharing their hereditary cancer stories, shaping the health information they share

4.

It Is Not Just the Royals Who Go Through Cancer.

5.

Joe Biden has prostate cancer with bone spread. An oncologist explains what you need to know


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot